Section 6. Conditions for Recovery of Funds
The Company agrees to immediately pay back to the DOC an amount of money equal to the Claw-Back Base multiplied by the appropriate percentage (the
“Appropriate Percentage”) with the product being the funds paid back to DOC (“Claw-Back”) in accordance with the following:
|
(a) |
In the event the Option is exercised against at least Parcel B and Parcel C, the Appropriate Percentage is
100%, however the Claw-Back would be capped at the Purchase Price. |
|
(b) |
In the event the Option is exercised against only Parcel C, the Appropriate Percentage is 100% if the Option
were exercised for the failure to create 3,875 Eligible Positions or 50% if the Option were exercised for the failure to create 6,000 Eligible Positions when at least 3,875 Eligible Positions were created. |
|
(c) |
In the event that the Option is not exercised but the Company fails to create 3,875 Eligible Positions by
December 31, 2026 and maintain employment at that level for two of the three succeeding Grant Years, the Appropriate Percentage is 100%. |
|
(d) |
In the event that the Option is not exercised but the Company creates at least 3,875 Eligible Positions by
December 31, 2026 and maintains employment at that level for two of the three succeeding Grant Years, but fails to (1) create 6,000 Eligible Positions and maintain those positions for two of three succeeding Grant Years by December 31, 2032 and
(2) invest $2 billion by December 31, 2029, then the Appropriate Percentage is 50%. |
|
(e) |
If the Company ceases operations on the Site for a period of 12 consecutive months prior to December 31, 2032,
the Appropriate Percentage is 100%. |
Section 7. Reporting
The Company must timely file all Annual Reports as described in Paragraph 3.7(b) of the CEDA, including the health insurance certification
required by N.C. Gen. Stat. § 143B-437.53(c). Failure timely file an Annual Report will result in a 0% compliance rating for that Grant Year and all future Grant Years, even if the CEDA is terminated. Thus, if the CEDA is terminated for
any reason, the Company will continue to file Annual Reports (including health insurance certifications) and pay applicable JDIG annual report filing fees in order to determine what the JDIG compliance rating should be for the purposes of this
Grant.
Section 8. Assignment
The Company may assign its interests under this Agreement only under the same terms and conditions as those specified in Paragraph 6.8(e) of
the CEDA for the assignment of its interests under the CEDA, which terms and conditions are incorporated by reference herein.
Section 9. Additional Provisions
9.1 Entire Agreement
This Agreement
supersedes all prior agreements between the DOC, the Guarantor or the Company and constitutes the entire agreement between the Parties as to the matters set forth herein, and supersedes all prior agreements and understandings, both written and oral,
among the Parties with respect to the subject matter hereof.
9.2 Execution
This Agreement may be executed in one or more counterparts, each of which, when executed, shall be deemed an original, and such counterpart,
together, shall constitute one and the same Agreement which shall be sufficiently evidenced by one of such original counterparts.
9.3 Construction and
Venue
This Agreement shall be construed and governed by the laws of the State of North Carolina. The Parties agree and submit,
solely for matters concerning this Agreement, to the exclusive jurisdiction of the courts of North Carolina and agree, solely for such purposes, that the only venue for any legal proceedings shall be Wake County, North Carolina. The place of this
Agreement, and all transactions and agreements relating to it, and their situs and forum, shall be Wake County, North Carolina, where all matters, whether sounding in contract, tort, or otherwise, relating to its validity, construction,
interpretation, and enforcement, shall be determined.
Section 10. Guaranty
10.1 The Guaranty
The Guarantor unconditionally and
irrevocably guarantees, as primary obligor and not as surety, the full, prompt, and punctual payment, and performance by the Company of all of its respective obligations, agreements, and covenants under and with respect to this Agreement.
10.2 Binding Obligation
This Guaranty is the valid and
binding obligation of the Guarantor, enforceable in accordance with its terms, and the making and performance of this Guaranty will not violate any provision of or result in the acceleration of any obligation under any instrument or agreement,
order, judgment, or decree to which the Guarantor is a party or by which it or any of its property is bound. This Guaranty shall operate as a continuing and absolute guaranty and shall remain in full force and effect without regard to, and shall not
be affected or impaired by, any amendment of the Agreement, any sale or transfer of all or any part of the Guarantor’s ownership interest in the Company or Related Member Parties, any voluntary or involuntary liquidation, dissolution, sale of
assets, insolvency, reorganization, bankruptcy or filing for bankruptcy of the Company, or the Guarantor or any subsidiary, any rescission of a payment made hereunder, or any extension of time or other forbearance, compromise, adjustment, or
indulgence granted to the Company by the DOC or the State.